Jump to content

New zealand drug showing promise in treatment Of LC!


Recommended Posts

A New Zealand medicine for lung cancer, which works by disrupting the blood vessels which are within the tumor, thereby inhibiting the blood flow, seems to reflect promising results, as has been shared by researchers who are expected to reported their findings at a cancer meeting scheduled to take place in California tomorrow.

The new medicine, discovered and developed at the Auckland University and named vadimezan, when given in combination with chemotherapy, managed to extend the survival time, confirmed Associate Professor Mark McKeage, a specialist in clinical pharmacology at theuniversity.

"Overall survival was improved numerically from a median of 8.8 to 14 months. he safety profile is favorable", he said.

The results have come after extensive studies conducted on patients suffering from advanced non-small-cell lung cancer.

The results will now be presented by Professor McKeage at the meeting "American Association for Cancer Research-International Association for the Study ofLung Cancer" in Coronado, California. The drug has been discovered by Bruce Baguley and William Denny, professors at the Auckland University.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.